Trial Outcomes & Findings for Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS) (NCT NCT03049969)

NCT ID: NCT03049969

Last Updated: 2024-07-09

Results Overview

The protocol is designed to have a decision-tree series of checkpoints that must be met in order to proceed at each step

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

15 participants

Primary outcome timeframe

End of treatment (up to 12 weeks)

Results posted on

2024-07-09

Participant Flow

Participant milestones

Participant milestones
Measure
Cognitive Remediation
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Overall Study
STARTED
15
Overall Study
COMPLETED
15
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cognitive Remediation
n=15 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Age, Continuous
46.33 years
STANDARD_DEVIATION 17.82 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants
n=5 Participants
Region of Enrollment
United States
15 participants
n=5 Participants

PRIMARY outcome

Timeframe: End of treatment (up to 12 weeks)

The protocol is designed to have a decision-tree series of checkpoints that must be met in order to proceed at each step

Outcome measures

Outcome measures
Measure
Cognitive Remediation
n=15 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Number of Participants Completing at Least 80% of the Targeted Number of Sessions.
10 Participants

PRIMARY outcome

Timeframe: End of treatment (up to 12 weeks)

Outcome measures

Outcome measures
Measure
Cognitive Remediation
n=15 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Number of Participants With Treatment Related Adverse Events
14 Participants

SECONDARY outcome

Timeframe: Baseline, end of treatment (up to 12 weeks)

VAS is a tool widely used to measure pain. A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 10 mm horizontal line, and this rating is then measured from the left edge (=VAS score). The total score range is 0 (no pain) to 10 (worst pain imaginable); the higher the score, the worse the pain.

Outcome measures

Outcome measures
Measure
Cognitive Remediation
n=12 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Change in Visual Analogue Scale (VAS) for Pain Score
-1.17 score on a scale
Standard Deviation 5.37

SECONDARY outcome

Timeframe: Baseline, end of treatment (up to 12 weeks)

This brief scale is comprised of 10 items measuring negative affect (e.g., upset, afraid). Individual items are scored 1-5, 1 being "very slightly or not at all" and 5 being "Extremely". The negative affect score is calculated by finding the sum of the 10 negative items. Scores range from 10 - 50. For the total negative score, a lower score indicates less of a negative affect.

Outcome measures

Outcome measures
Measure
Cognitive Remediation
n=11 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Change in Negative Affect Score From the Positive and Negative Affect Scale (PANAS)
-3 score on a scale
Standard Deviation 5.74

SECONDARY outcome

Timeframe: Baseline, end of treatment (up to 12 weeks)

This brief scale is comprised of 10 items measuring positive affect (e.g., excited, inspired). Individual items are scored 1-5, 1 being "very slightly or not at all" and 5 being "Extremely". The positive affect score is calculated by finding the sum of the 10 positive items. Scores range from 10 - 50. For the total positive score, a higher score indicates more of a positive affect.

Outcome measures

Outcome measures
Measure
Cognitive Remediation
n=12 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Change in Positive Affect Score From the Positive and Negative Affect Scale (PANAS)
-1.17 score on a scale
Standard Deviation 5.37

SECONDARY outcome

Timeframe: Baseline, end of treatment (up to 12 weeks)

The SDMT is a cognitive processing speed test. Participants are given a key of nine symbol-digit pairs along with a sequence of symbols. They are then asked to use the key to match as many symbols in the sequence to their corresponding numbers as possible within 90 seconds. The score is the number of correctly coded items from 0-110 in 90 seconds. Lower scores indicate cognitive decline.

Outcome measures

Outcome measures
Measure
Cognitive Remediation
n=8 Participants
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Change in Symbol Digit Modalities Test (SDMT) Score
0.75 score on a scale
Standard Deviation 4.56

Adverse Events

Cognitive Remediation

Serious events: 0 serious events
Other events: 14 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Cognitive Remediation
n=15 participants at risk
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed. tDCS stimulation: up to 4.0 mA, dorsolateral prefrontal cortex (montage dependent on specific area of deficit) while completing cognitive training tasks
Skin and subcutaneous tissue disorders
Tingling Sensation
93.3%
14/15 • 12 Weeks
Skin and subcutaneous tissue disorders
Itching Sensation
93.3%
14/15 • 12 Weeks
Skin and subcutaneous tissue disorders
Warmth Sensation
93.3%
14/15 • 12 Weeks

Additional Information

Leigh Charvet, MD

NYU Langone Health

Phone: 9294555141

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place